undamentalytics Newsletter

Kestra Medical Technologies vs Sanara Medtech

Kestra Medical Technologies and Sanara Medtech are similar in size: $95.1m and $103m of revenue in their latest fiscal years. Kestra Medical Technologies grew faster (59.0% against 19.0%). Sanara Medtech kept more of each dollar of sales as profit: a net margin of -36.4% against -138.4%. Kestra Medical Technologies carries less debt relative to equity (16.4% against 790.2%).

Latest fiscal yearKestra Medical TechnologiesKMTS, 2026Sanara MedtechSMTI, 2025
Revenue $95.1m $103m
Revenue growth 59.0% 19.0%
Net income −$132m −$37.6m
Operating margin -141.6% 7.1%
Net margin -138.4% -36.4%
Return on equity -56.6% -165.7%
Free cash flow −$117m $2.2m
Cash $99.7m $16.6m
Total debt $42.6m $46.9m
Debt to equity 16.4% 790.2%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 443 108
Market value $1.74bn $295m
Price vs our value range — —
Moat score — 34 (Weak)
Insider trades, 12 months 1 buys, 49 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.